Proton therapy for partial breast irradiation: Rationale and considerations Review
| Authors: | Choi, J. I.; Fox, J.; Bakst, R.; Hasan, S.; Press, R. H.; Chhabra, A. M.; Yeh, B.; Simone, C. B. 2nd; Cahlon, O. |
| Review Title: | Proton therapy for partial breast irradiation: Rationale and considerations |
| Abstract: | In an era of continued advancements in personalized medicine for the treatment of breast cancer, select patients with early stage breast cancer may be uniquely poised to benefit from partial breast irradiation (PBI) delivered with proton therapy. PBI presents an opportunity to improve quality of life during treatment with a significantly shorter treatment duration. By targeting less non-target breast tissue, excess radiation exposure and resulting toxicities are also reduced. Proton therapy represents a precision radiotherapy technology that builds on these advantages by further limiting the normal tissue exposure to unnecessary radiation dose not only to uninvolved breast tissue but also the underlying thoracic organs including the heart and lungs. Herein, we present a concise review of the rationale for the use of proton therapy for PBI, evidence available to date, and practical considerations in the implementation and use of proton therapy for this indication. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
| Keywords: | breast cancer; radiation therapy; proton therapy; partial breast irradiation; precision medicine |
| Journal Title: | Journal of Personalized Medicine |
| Volume: | 11 |
| Issue: | 4 |
| ISSN: | 2075-4426 |
| Publisher: | MDPI |
| Date Published: | 2021-04-01 |
| Start Page: | 289 |
| Language: | English |
| DOI: | 10.3390/jpm11040289 |
| PROVIDER: | scopus |
| PMCID: | PMC8069416 |
| PUBMED: | 33918662 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 June 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work